Table 1.
Characteristics | TCGA Total (n = 372) | GEO Total (n = 165) | |
---|---|---|---|
Age (years) | <60 | 79 (21.2%) | 42 (25.5%) |
≥60 | 293 (78.7%) | 123 (74.5%) | |
Gender | Male | 276 (74.2%) | 135 (81.8%) |
Female | 96 (25.8%) | 30 (18.2%) | |
T stage 1 | T0 | 1 (0.3%) | 0 |
T1 | 4 (1.1%) | 80 (48.5%) | |
T2 | 116 (31.2%) | 31 (18.8%) | |
T3 | 193 (51.9%) | 19 (11.5%) | |
T4 | 57 (15.3%) | 11 (6.7%) | |
Tx | 1 (0.3%) | 24 (14.5%) | |
T stage 2 | T0–2 | 121 (32.5%) | 111 (67.3%) |
T3–4 | 251 (67.5%) | 30 (18.2%) | |
Tx | 1 (0.3%) | 24 (14.5%) | |
Lymph node metastasis | Yes | 124 (33.3%) | 15 (9.1%) |
No | 221 (59.4%) | 149 (90.3%) | |
Unknown | 27 (7.3%) | 1 (0.61%) | |
Metastasis | Yes | 8 (2.2%) | 7 (4.2%) |
No | 183 (49.2%) | 158 (95.8%) | |
Unknown | 181 (48.7%) | 0 | |
Diagnosis subtype | Papillary | 117 (31.5%) | NA |
Non-papillary | 250 (67.2%) | NA | |
Unknown | 5 (1.3%) | NA | |
Histologic grade | High | 351 (94.4) | 60 (36.4%) |
Low | 19 (5.1%) | 105 (63.6%) | |
Unknown | 2 (0.5%) | 0 | |
Vital status | Dead | 166 (44.6%) | 69 (41.8%) |
Alive | 206 (55.4%) | 96 (58.2%) |
NA, Not Applicable.